title: Radiosensitivity of permanent human bone marrow stromal cell lines: effect of dose rate.
abstract: In contrast to the dose-rate independent X ray killing observed with human bone marrow hematopoietic stem cells, bone marrow adherent stromal cells from the same fresh marrow harvests demonstrate increased radiation resistance at low dose rate (LDR) (5 cGy/min), compared to high dose rate (HDR) irradiation (120-200 cGy/min). Physiologic changes observed in plateau phase bone marrow cells after LDR irradiation in vivo and in vitro suggested that marrow stromal cells might be heterogeneous in LDR irradiation repair. Five permanent clonal bone marrow stromal lines were derived from a single human marrow donor. Each cell line was positive for markers of fibroblasts including: immunohistochemically detectable fibronectin, collagen, acid phosphatase, and nonspecific esterase, and was negative for Factor VIII, alkaline phosphatase, lysozyme and several markers of marrow macrophages. The x-irradiation survival curve of each cell line was determined at LDR and HDR in vitro. Cell lines KM102, KM103, KM104, and KM105 each demonstrated a significant (p less than .05) increase in radioresistance at LDR (D0 = 142, n = 2.9; D0 = 131, n = 2.5; D0 = 145, n = 2.1 and D0 = 127, n = 2.1 respectively) compared to HDR: (D0 = 111, n = 2.1; D0 = 94, n = 3.5; D0 = 99, n = 3.5 and D0 = 95, n = 2.1 respectively). In contrast, cell line KM101 demonstrated no significant change in radiosensitivity relative to dose rate at LDR (D0 = 113, n = 3.3) compared to HDR, D0 = 114, n = 3.3. Cell line KM101 was more supportive than the other lines of cocultivated hemopoietic cells in vitro. Subclones of KM101 and KM104 selected by retroviral vector transfer of the neor gene for growth in the antibiotic neomycin-analogue G418, maintained the stably associated radiobiologic properties of each parent clonal line. These data indicate significant heterogeneity in the LDR irradiation response of clonal stromal cell lines derived from human bone marrow.
authors.affiliation: Department of Radiation Oncology, University of Massachusetts Medical Center, Worcester 01605.
authors.forename: T J
authors.initials: TJ
authors.lastname: FitzGerald
authors.forename: M A
authors.initials: MA
authors.lastname: Santucci
authors.forename: K
authors.initials: K
authors.lastname: Harigaya
authors.forename: B
authors.initials: B
authors.lastname: Woda
authors.forename: M
authors.initials: M
authors.lastname: McKenna
authors.forename: M A
authors.initials: MA
authors.lastname: Sakakeeny
authors.forename: J H
authors.initials: JH
authors.lastname: Pierce
authors.forename: K
authors.initials: K
authors.lastname: Kase
authors.forename: C A
authors.initials: CA
authors.lastname: Holland
authors.forename: J S
authors.initials: JS
authors.lastname: Greenberger
mesh_terms: D001853:Bone Marrow / Q000528:radiation effects*; D001854:Bone Marrow Cells; D002460:Cell Line; D002470:Cell Survival / Q000528:radiation effects; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D066298:In Vitro Techniques; D011829:Radiation Dosage; D011836:Radiation Tolerance